期刊文献+

铜绿假单胞菌对亚胺培南的耐药性分析及机制探讨 被引量:16

Imipenem-resistant Mechanism of Pseudomonas Aeruginosa
原文传递
导出
摘要 目的:研究铜绿假单胞菌对亚胺培南的耐药性及其机制。方法:取痰液中培养分离的铜绿假单胞菌55株,经K-B法检测耐药性。采用外膜蛋白图谱,对其外膜蛋白OprD2进行SDS-PAGE分析,双纸片增效法检测金属β-内酰胺酶。结果:根据耐药性分为铜绿假单胞菌亚胺培南菌耐药36株和敏感19株。铜绿假单胞菌亚胺培南耐药株不同程度OprD2减少,耐药组OprD2相对含量明显低于敏感组(P<0.01);产金属β-内酰胺酶6株,检出率10.9%。结论:OprD2的减少和产金属β-内酰胺酶是铜绿假单胞菌对亚胺培南耐药的主要原因。 OBJECTIVE: To investigate the mechanism of imipenem - resistance in clinical isolates of Pseudomonas aeruginos (PA) . METHODS: 55 strains of PA had been isolated from sputum specimen in clinic and their drug sensitivity to imipenem was tested by K- B slip diffusion method. Their amount of outer membrane protein OprD2 was analyzed by SDS - PAGE with outer membrane protein profiles. Metallo - β - lactamases (MBLs) was detected by double - disk synergy test (DDST) . RESULTS: 36 strains of imipenem - resistant and 19 strains of imipenem - sensitive PA isolated were studied. The amount of OprD2 showed a various degree of reduction in all resistant isolates, and the relative amount of OprD2 in resistant isolates were significantly lower than in sensitive isolates (P〈 0.01) . 6 (10.9%) were MBLs-producing strains. CONCLU- SIONS: The reduction of OprD2 and MBLs are the main factors accountable for Pseudomonas aeruginosas' s resistance to imipenem. KEY WORDS
出处 《中国药房》 CAS CSCD 北大核心 2008年第17期1317-1318,共2页 China Pharmacy
关键词 铜绿假单胞菌 亚胺培南 耐药 OPRD2 金属Β-内酰胺酶 Pseudomonas aeruginos Imipenem Resistance OprD2 Metallo - β - lactamases
  • 相关文献

参考文献9

二级参考文献26

  • 1李智山,邓三季,杨燕,赵建忠.铜绿假单胞菌氨基糖苷类修饰酶基因分子流行病学研究[J].中华医院感染学杂志,2005,15(2):134-136. 被引量:21
  • 2Lauretti L, Riccio ML, Mazzariol A, et al. Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate[J]. Antimicrob Agents Chemother, 1999, 43(7): 1584-1590.
  • 3Poirel L, Naas T, Nicolas D, et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France[J]. Antimicrob Agents Chemother, 2000, 44(4): 89
  • 4Lee K, Lim JB, Yum JH, et al. blaVIM-2 cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital[J]. Antimicrob Agents Chemother, 2002, 46(4): 1053-1058.
  • 5Livermore DM, Woodford N. Carbapenemases: a problem in waiting? Curr Opin Microbiol, 2000, 3(5): 489-495.
  • 6Yan JJ, Hsueh PR, Ko WC, et al. Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme[J]. Antimicrob Agents Chemother, 2001, 45(18): 2224-2228.
  • 7Concha NO, Janson CA, Rowling P, et al. Crystal structure of the IMP-1 metallo-β-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor[J]. Biochemistry, 2000
  • 8Evans K,Poole K.The MexA-mexB-OprM multidrug efflux system of pseudomonas aeruginosa is growth Phase regulated[J].FEMS Microbiol Lett,1999,173(1):35.
  • 9Murthy SK, Balch AL, Smith RP, etal. Oropharyngeal and fecal carriage of Pseudomonas aeruginosa in hospital patients[J]. JClin Microbiol, 1989, 27(1):35-40
  • 10National Committee for Clinical Laboratory Standard. Approved standardM7-A4.Methods for dilution antimicrobiol susceptibility tests for bacteria that growaerobically[S]. 4*!th ed, NCCLS, Villanova, Pa. 1997

共引文献123

同被引文献116

引证文献16

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部